The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Metastatic renal cell carcinoma (mRCC) primary refractory patients to first-line IO-TKI and IO-IO combinations (Meet-URO 33 analysis).
 
Davide Bimbatti
No Relationships to Disclose
 
Alessio Signori
No Relationships to Disclose
 
Sebastiano Buti
Consulting or Advisory Role - Astellas Pharma; BMS; Ipsen; Merck; Merck/Pfizer; MSD; Pfizer
Speakers' Bureau - Astellas Pharma; BMS; Ipsen; Merck; Merck/Pfizer; MSD; Pfizer
Research Funding - Novartis (Inst); Pfizer (Inst)
 
Francesca Vignani
No Relationships to Disclose
 
Federico Paolieri
No Relationships to Disclose
 
Cinzia Ortega
No Relationships to Disclose
 
Lucia Fratino
No Relationships to Disclose
 
Emilia Cocorocchio
No Relationships to Disclose
 
Cristian Lolli
No Relationships to Disclose
 
Claudia Mucciarini
No Relationships to Disclose
 
Martina Buffoni
No Relationships to Disclose
 
Diego Zara
Travel, Accommodations, Expenses - Merck KGaA
 
Valeria Sardaro
No Relationships to Disclose
 
Debora D'Ausilio
No Relationships to Disclose
 
Stefania Di Girolamo
No Relationships to Disclose
 
Claudia Mosillo
No Relationships to Disclose
 
Letizia Galeasso
No Relationships to Disclose
 
Anna Tortorella
No Relationships to Disclose
 
Michele Maffezzoli
No Relationships to Disclose
 
Sara Elena Rebuzzi
No Relationships to Disclose